Patient-reported opioid consumption after fracture surgery demonstrated good to excellent agreement with traditional blister-pack pill counts.

NeuroTherapia, Inc., a clinical-stage company focused on developing oral therapies for neurodegenerative diseases, has ...

Late-breaking results from the Phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate ...

FDA rejects Replimune's melanoma therapy despite breakthrough designation, raising urgent questions about regulatory ...

The FDA has gained a reputation during the past year for being inconsistently flexible, particularly when it comes to rare ...

Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced ...

Organogenesis Holdings Inc. looks undervalued at distressed multiples; new DFU RCT data supports coverage despite 2026 CMS ...

The largest analysis of psychedelic brain imaging to date offers a clearer picture of how psychedelic drugs affect the brain.

Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced a $50 million growth financing.

Major Korean K-pop agencies are accused of greenwashing when promoting digital "smart albums," while maintaining aggressive ...

The data are limited but suggest the tricuspid valve procedure can do more than improve health status, researchers say.